Trial Profile
rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics for Healthy Subjects in the Phase Ⅰ Clinical Study
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 11 Sep 2019
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Shenyang Sunshine Pharmaceutical
- 11 Feb 2015 New trial record